Literature DB >> 23766416

PiHelper: an open source framework for drug-target and antibody-target data.

Bülent Arman Aksoy1, Jianjiong Gao, Gideon Dresdner, Weiqing Wang, Alex Root, Xiaohong Jing, Ethan Cerami, Chris Sander.   

Abstract

MOTIVATION: The interaction between drugs and their targets, often proteins, and between antibodies and their targets, is important for planning and analyzing investigational and therapeutic interventions in many biological systems. Although drug-target and antibody-target datasets are available in separate databases, they are not publicly available in an integrated bioinformatics resource. As medical therapeutics, especially in cancer, increasingly uses targeted drugs and measures their effects on biomolecular profiles, there is an unmet need for a user-friendly toolset that allows researchers to comprehensively and conveniently access and query information about drugs, antibodies and their targets.
SUMMARY: The PiHelper framework integrates human drug-target and antibody-target associations from publicly available resources to help meet the needs of researchers in systems pharmacology, perturbation biology and proteomics. PiHelper has utilities to (i) import drug- and antibody-target information; (ii) search the associations either programmatically or through a web user interface (UI); (iii) visualize the data interactively in a network; and (iv) export relationships for use in publications or other analysis tools. AVAILABILITY: PiHelper is a free software under the GNU Lesser General Public License (LGPL) v3.0. Source code and documentation are at http://bit.ly/pihelper. We plan to coordinate contributions from the community by managing future releases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23766416      PMCID: PMC3722529          DOI: 10.1093/bioinformatics/btt345

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


1 INTRODUCTION

In cancer biology, systems pharmacology and perturbation biology, researchers designing targeted drug experiments often need to choose targeted drugs and antibodies of interest for their experimental studies. For such studies, drug- and antibody-target databases are valuable resources and are increasingly publicly available in computable formats. Unfortunately, this information is in separate databases that use mostly incompatible formats, making it difficult to integrate data across different resources. This, coupled with strict constraints on distribution of the data, hinders access to up-to-date integrated data. Here we describe an open-source framework, PiHelper, for easy aggregation, integration and visualization of drug- and antibody-target data from multiple sources. PiHelper provides a platform-independent command-line tool to help users, with minimal configuration, import and export drug- and antibody-target information in a human- and gene-centric manner; a Java application programming interface and a REST-ful (Representational State Transfer) web service to facilitate programmatic access to the aggregated data; and a web-based UI to help users query data in a gene-centric manner and export the results as an image or undirected binary network. We believe PiHelper will facilitate hypothesis generation and design of new experiments by enabling researchers to access and query integrated drug-target and antibody-target data from multiple resources in an automatic way.

2 COMPONENTS

2.1 Administration module

The administration module provides a command-line interface for users to import data into a database or export the aggregated data to tab-delimited format for further analysis. The importer component supports automatic fetching of background gene information, gene sets, gene-centric drug-target and antibody-target annotations from multiple resources (Table 1). Importing data from these resources is accomplished in an automatic manner through PiHelper’s admin command-line interface. The admin module contains specific data converters for each resource and frees the user from handling different file formats and merging data across resources. The user also has the option to import drug- and antibody-target data from custom tab-delimited files.
Table 1.

PiHelper enables integration of 10 publicly available drug-target and drug-antibody resources

Data resourceType of data
DrugBank (Knox et al., 2011)Drug-target
KEGG Drug (Kanehisa et al., 2012)Drug-target
Rask-Andersen et al., 2011Drug-target
GDSC (Yang et al., 2013)Drug-target
Garnett et al., 2012Drug-target
Cancer.gov http://cancer.govDrug-annotation
The Human Protein Atlas (Uhlen et al., 2010)Antibody-target
Tibes et al., 2006Antibody-target
Pawlak et al., 2002Antibody-target
Pathway Commons (Cerami et al., 2011)Gene-sets

Note: KEGG, Kyoto Encyclopedia of Genes and Genomes; GDSC, The Genomics of Drug Sensitivity in Cancer

PiHelper enables integration of 10 publicly available drug-target and drug-antibody resources Note: KEGG, Kyoto Encyclopedia of Genes and Genomes; GDSC, The Genomics of Drug Sensitivity in Cancer Once the database is populated through the admin tool, the exporter component can be used to export all drug and antibody data to a tab-delimited text format (TSV). These files can then be used for further analysis tools, e.g. by importing the data into Cytoscape as a binary network and running graph-based queries or visualizing larger networks (Shannon ).

2.2 Web-based UI

The web-based UI distributed as a part of PiHelper enables users to query antibodies and drugs in a gene-centric manner (Povey ). It also helps visualize the results as a binary network and export the final network in either scalable vector graphics (SVG), portable network graphics, GraphML or simple interaction formats. The visualization of the query results as an interactive network is accomplished through the Cytoscape Web library (Lopes ). The web-based UI features automatic validation of the gene names, pre-loaded gene sets representing most of the well-known canonical pathways in the query page; details for a gene, drug, antibody or the targeting interaction upon clicking on the corresponding element within the network; and options to expand the network based on either genes or drugs in the network and to download the network for external use (Fig. 1).
Fig. 1.

Sample target network visualization: results showing all drug and antibody associations of EGFR and ERBB2 genes. PiHelper web UI allows exporting the network to various formats, e.g. SVG and Simple Interaction Formats

Sample target network visualization: results showing all drug and antibody associations of EGFR and ERBB2 genes. PiHelper web UI allows exporting the network to various formats, e.g. SVG and Simple Interaction Formats

2.3 Core module

The core module provides the model Java classes and basic finder methods. The model classes consist of basic elements, such as Drug, Gene and DrugTarget, which capture drug– and antibody–gene relationships. These elements, together with their querying methods, help developers build custom applications or analysis tools that depend on drug or antibody annotation data. Besides the Java application programming interface, the core module also includes a web service component that provides basic querying methods through REST protocols. The web service supports obtaining the results in either JavaScript Object Notation or HyperText Markup Language. The former provides flexibility for developers who prefer other programming languages than Java; the latter enables users to interact with the database via their web browser of choice.
  12 in total

1.  The HUGO Gene Nomenclature Committee (HGNC).

Authors:  S Povey; R Lovering; E Bruford; M Wright; M Lush; H Wain
Journal:  Hum Genet       Date:  2001-10-24       Impact factor: 4.132

2.  Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis.

Authors:  Michael Pawlak; Eginhard Schick; Martin A Bopp; Michael J Schneider; Peter Oroszlan; Markus Ehrat
Journal:  Proteomics       Date:  2002-04       Impact factor: 3.984

3.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 4.  Trends in the exploitation of novel drug targets.

Authors:  Mathias Rask-Andersen; Markus Sällman Almén; Helgi B Schiöth
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

5.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

6.  Cytoscape Web: an interactive web-based network browser.

Authors:  Christian T Lopes; Max Franz; Farzana Kazi; Sylva L Donaldson; Quaid Morris; Gary D Bader
Journal:  Bioinformatics       Date:  2010-07-23       Impact factor: 6.937

7.  DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.

Authors:  Craig Knox; Vivian Law; Timothy Jewison; Philip Liu; Son Ly; Alex Frolkis; Allison Pon; Kelly Banco; Christine Mak; Vanessa Neveu; Yannick Djoumbou; Roman Eisner; An Chi Guo; David S Wishart
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971

8.  Pathway Commons, a web resource for biological pathway data.

Authors:  Ethan G Cerami; Benjamin E Gross; Emek Demir; Igor Rodchenkov; Ozgün Babur; Nadia Anwar; Nikolaus Schultz; Gary D Bader; Chris Sander
Journal:  Nucleic Acids Res       Date:  2010-11-10       Impact factor: 16.971

9.  KEGG for integration and interpretation of large-scale molecular data sets.

Authors:  Minoru Kanehisa; Susumu Goto; Yoko Sato; Miho Furumichi; Mao Tanabe
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

10.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.

Authors:  Wanjuan Yang; Jorge Soares; Patricia Greninger; Elena J Edelman; Howard Lightfoot; Simon Forbes; Nidhi Bindal; Dave Beare; James A Smith; I Richard Thompson; Sridhar Ramaswamy; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Cyril Benes; Ultan McDermott; Mathew J Garnett
Journal:  Nucleic Acids Res       Date:  2012-11-23       Impact factor: 16.971

View more
  7 in total

1.  A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials.

Authors:  Kaitlyn M Gayvert; Neel S Madhukar; Olivier Elemento
Journal:  Cell Chem Biol       Date:  2016-09-15       Impact factor: 8.116

2.  A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.

Authors:  Kaitlyn M Gayvert; Etienne Dardenne; Cynthia Cheung; Mary Regina Boland; Tal Lorberbaum; Jackline Wanjala; Yu Chen; Mark A Rubin; Nicholas P Tatonetti; David S Rickman; Olivier Elemento
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

3.  Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network.

Authors:  Helge G Roider; Nadia Pavlova; Ivaylo Kirov; Stoyan Slavov; Todor Slavov; Zlatyo Uzunov; Bertram Weiss
Journal:  BMC Bioinformatics       Date:  2014-03-11       Impact factor: 3.169

4.  Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation.

Authors:  Lingling Duan; Zhenhua Chen; Jun Lu; Yanping Liang; Ming Wang; Carlos M Roggero; Qing-Jun Zhang; Jason Gao; Yong Fang; Jiazheng Cao; Jian Lu; Hongwei Zhao; Andrew Dang; Rey-Chen Pong; Elizabeth Hernandez; Chun-Mien Chang; David T Hoang; Jung-Mo Ahn; Guanghua Xiao; Rui-Tao Wang; Kai-Jiang Yu; Payal Kapur; Josep Rizo; Jer-Tsong Hsieh; Junhang Luo; Zhi-Ping Liu
Journal:  Nucleic Acids Res       Date:  2019-12-16       Impact factor: 19.160

5.  Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles.

Authors:  Bülent Arman Aksoy; Emek Demir; Özgün Babur; Weiqing Wang; Xiaohong Jing; Nikolaus Schultz; Chris Sander
Journal:  Bioinformatics       Date:  2014-03-24       Impact factor: 6.937

6.  Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.

Authors:  Yasser El-Manzalawy; Tsung-Yu Hsieh; Manu Shivakumar; Dokyoon Kim; Vasant Honavar
Journal:  BMC Med Genomics       Date:  2018-09-14       Impact factor: 3.063

7.  A machine learning and network framework to discover new indications for small molecules.

Authors:  Coryandar Gilvary; Jamal Elkhader; Neel Madhukar; Claire Henchcliffe; Marcus D Goncalves; Olivier Elemento
Journal:  PLoS Comput Biol       Date:  2020-08-07       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.